Anand B. Karnad

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy

Shujie Zhao, Chen Chen, Katherine W. Chang et al. · Clinical Cancer Research · 2016 · 176 citations

Medicine, Cell Biology, Oncology +16

The automated complete blood cell count. Use of the red blood cell volume distribution width and mean platelet volume in evaluating anemia and thrombocytopenia

Anand B. Karnad · Archives of Internal Medicine · 1985 · 97 citations

Medicine, Hematology, Hematology Physiology +13

Management of the unknown primary carcinoma: Long‐term follow‐up on a negative PET scan and negative panendoscopy

Frank R. Miller, Anand B. Karnad, Tony Y. Eng et al. · Head & Neck · 2007 · 96 citations

Medicine, Oncology, Radiology +17

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study

Mehdi Hamadani, Graham P. Collins, Paolo F. Caimi et al. · The Lancet Haematology · 2021 · 86 citations · Full text

Medicine, Immunology, Oncology +17